Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Liver Regeneration

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Coloenteric fistula in a young patient with recurrent diverticulitis: A case report and review of the literature.

The Netherlands journal of medicine·2016

Same author

Antimicrobial biosurfactants from marine Bacillus circulans: extracellular synthesis and purification.

Letters in applied microbiology·2009

Same author

Feasibility and safety of autologous intracoronary stem cell transplantation in patients of non ischemic dilated cardiomyopathy.

Indian heart journal·2009

Same author

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma.

Leukemia·2009

Same author

Search for gravitational-wave bursts from soft gamma repeaters.

Physical review letters·2008

Same author

Effect of surfactant-perturbed nanocaging on the ground and excited state proton transfer reaction.

The journal of physical chemistry. A·2008

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Hepatitis C recurrence after liver transplantation.

I Bhat¹, S Mukherjee

¹Section of Gastroenterology and Hepatology, Nebraska Medical Center, Omaha, NE 68198-3285, USA.

Panminerva Medica

|March 3, 2010

Summary

Hepatitis C recurrence after liver transplant (LT) is common, leading to cirrhosis and potential retransplantation. Strategies focus on managing risk factors and optimizing treatment for recurrent hepatitis C to improve patient outcomes.

More Related Videos

Vascular Reconstruction with the Cuff Technique in Mouse Orthotopic Liver Transplantation

Vascular Reconstruction with the Cuff Technique in Mouse Orthotopic Liver Transplantation

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Jun 15, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Vascular Reconstruction with the Cuff Technique in Mouse Orthotopic Liver Transplantation

Vascular Reconstruction with the Cuff Technique in Mouse Orthotopic Liver Transplantation

Published on: December 1, 2023

Area of Science:

Hepatology
Transplant Surgery
Virology

Background:

Hepatitis C (HCV) is the primary reason for liver transplantation (LT) in the US.
Recurrent HCV post-LT is universal, causing significant morbidity and mortality, with up to 30% developing cirrhosis within five years.
Established cirrhosis post-LT carries a ~40% annual risk of hepatic decompensation.

Purpose of the Study:

To review risk factors for accelerated recurrent hepatitis C after liver transplantation.
To discuss strategies for limiting severe recurrence and managing post-transplant hepatitis C.
To highlight challenges and controversies in treating recurrent hepatitis C post-LT.

Main Methods:

Review of risk factors for accelerated HCV recurrence, including pre-transplant viral load, donor age, ischemic time, and coinfections (CMV, HIV).
Discussion of preventative strategies: donor selection, early CMV recognition, and immunosuppression minimization.
Analysis of current treatment approaches for recurrent HCV, including limitations and side effects of pegylated interferon and ribavirin.

Main Results:

Accelerated recurrence is linked to high pre-transplant viral load, older donor age, prolonged ischemia, CMV/HIV coinfection, and intense immunosuppression.
Preventative measures can mitigate recurrence risk.
Current treatments for recurrent HCV yield low sustained viral rates (<30%) and are associated with significant side effects.

Conclusions:

Effective management of recurrent hepatitis C post-LT requires careful consideration of risk factors and immunosuppression.
Treatment initiation is often empiric, typically upon early fibrosis development, but efficacy is limited.
Retransplantation may be necessary for patients with decompensated cirrhosis due to recurrent HCV.